Amphotericin-b-induced chronic kidney disease in a post-covid-19 patient with widespread rhinocerebral mucormycosis and pneumonia: A CASE REPORT
CONCLUSION: While COVID-19 has presented challenges and uncertainties, it has also provided valuable insights into the interactions between infectious agents and the human body. Continued research and vigilance are necessary to mitigate the impact of co-infections and improve outcomes for patients.PMID:37537934 | DOI:10.2174/1574886318666230804101539
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Nishant Johri Ambika Choudhary Ujjawal Rawat Maheshwari Vengat Source Type: research
More News: Abelcet | Chronic Kidney Disease | Chronic Obstructive Pulmonary | COVID-19 | Diabetes | Drugs & Pharmacology | Endocrinology | Hypertension | Pandemics | Pneumonia | Urology & Nephrology